EDV Nanocell

EDV Nanocells for Recurrent, Metastatic Pancreatic Cancer Paper to be presented at ASCO

NEW YORK and SYDNEY: EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV nanocell platform for targeted cyto-immunotherapy in…